US Drug Recall Register

Is Progesterone recalled?

Yes — there is an active recall. 9 ongoing FDA recalls mention Progesterone (171 total). Check the affected lots below.

Recalls are matched by product description. A recall usually affects specific lots, not every package of Progesterone. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed.

Class II · Moderate risk Terminated

Progesterone Sesame Oil 10ml Mdv 100mg/Ml Inj

Reason Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.

Key Pharmacy and Compounding Center D-0775-2017
Class II · Moderate risk Terminated

17-0h Progesterone 250mg/Ml

Reason Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.

Well Care Compounding Pharmacy D-0978-2016
Class II · Moderate risk Terminated

All progesterone Products

Reason Lack of Processing Controls

Reliable Rexall-A Compounding Pharmacy D-1073-2016
Class II · Moderate risk Terminated

progesterone/testosterone

Reason Lack of Assurance of Sterility: Firm is recalling all unexpired lots of sterile compounded products after FDA inspection found concerns of lack of sterility assurance.

Abbott's Compounding Pharmacy, Inc. D-0715-2016
Class II · Moderate risk Terminated

hydroxyprogesterone w/ pres

Reason Lack of Assurance of Sterility: Firm is recalling all unexpired lots of sterile compounded products after FDA inspection found concerns of lack of sterility assurance.

Abbott's Compounding Pharmacy, Inc. D-0683-2016
Class II · Moderate risk Terminated

hydroxyprogesterone in sesame 250 mg/mL

Reason Lack of Assurance of Sterility: Firm is recalling all unexpired lots of sterile compounded products after FDA inspection found concerns of lack of sterility assurance.

Abbott's Compounding Pharmacy, Inc. D-0682-2016
Class II · Moderate risk Terminated

Progesterone Cyp Inj

Reason Lack of Assurance of Sterility

Western Drug D-0445-2016
Class II · Moderate risk Terminated

MedroxyPROGESTERone/Lidocaine

Reason Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

US Compounding Inc NDC 62295-3113-07 D-0263-2016
Class II · Moderate risk Terminated

Progesterone 100 mg/mL Ethyl Oleate Injection

Reason Lack of Assurance of Sterility: A recall of all compounded sterile preparations within expiry is being initiated due to observations associated with poor sterile production practices resulting in a lack of sterility assurance for their finished drugs.

Kalman Health & Wellness, Inc. dba Essential Wellness Pharma D-322-2016
Class II · Moderate risk Terminated

Progesterone 100 mg/mL in Corn Oil Injection

Reason Lack of Assurance of Sterility: A recall of all compounded sterile preparations within expiry is being initiated due to observations associated with poor sterile production practices resulting in a lack of sterility assurance for their finished drugs.

Kalman Health & Wellness, Inc. dba Essential Wellness Pharma D-321-2016
Class II · Moderate risk Terminated

Progesterone 100 mg/mL IM* Injection in Sesame Oil

Reason Lack of Assurance of Sterility: A recall of all compounded sterile preparations within expiry is being initiated due to observations associated with poor sterile production practices resulting in a lack of sterility assurance for their finished drugs.

Kalman Health & Wellness, Inc. dba Essential Wellness Pharma D-320-2016
Class II · Moderate risk Terminated

17-Alpha Hydroxyprogesterone 250 mg/mL in Sesame Oil Injection

Reason Lack of Assurance of Sterility: A recall of all compounded sterile preparations within expiry is being initiated due to observations associated with poor sterile production practices resulting in a lack of sterility assurance for their finished drugs.

Kalman Health & Wellness, Inc. dba Essential Wellness Pharma D-300-2016
Class II · Moderate risk Terminated

17-Alpha Hydroxyprogesterone 250 mg/mL in Castor Oil Injection

Reason Lack of Assurance of Sterility: A recall of all compounded sterile preparations within expiry is being initiated due to observations associated with poor sterile production practices resulting in a lack of sterility assurance for their finished drugs.

Kalman Health & Wellness, Inc. dba Essential Wellness Pharma D-299-2016
Class II · Moderate risk Terminated

Progesterone

Reason Lack of Assurance of Sterility; all sterile human compounded drugs within expiry

JD & SN Inc., dba Moses Lake Professional Pharmacy D-0118-2016
Class II · Moderate risk Terminated

Progesterone

Reason Lack of Assurance of Sterility; all sterile human compounded drugs within expiry

JD & SN Inc., dba Moses Lake Professional Pharmacy D-0117-2016
Class II · Moderate risk Terminated

Progesterone

Reason Lack of Assurance of Sterility; all sterile human compounded drugs within expiry

JD & SN Inc., dba Moses Lake Professional Pharmacy D-0116-2016
Class II · Moderate risk Terminated

Medroxyprogesterone Acetate

Reason Lack of Assurance of Sterility; all sterile human compounded drugs within expiry

JD & SN Inc., dba Moses Lake Professional Pharmacy D-0101-2016
Class II · Moderate risk Terminated

Hydroxyprogesterone Caproate Oil

Reason Lack of Assurance of Sterility; all sterile human compounded drugs within expiry

JD & SN Inc., dba Moses Lake Professional Pharmacy D-0100-2016
Class II · Moderate risk Terminated

SIH-Hydroxyprogesterone Caproate 250

Reason Lack of Assurance of Sterility: Due to lack of documentation of proper environmental monitoring during the time in which the medication was produced.

The Apothecary Shoppe LLC D-1315-2015
Class II · Moderate risk Terminated

17-Hydroxyprogesterone 250 mg/mL Injectable

Reason Lack of Assurance of Sterility: Process deficiencies were observed in the sterile ophthalmic and injectable products that could have compromised the sterility of the product.

Liberty Drug & Surgical D-1391-2015
Class II · Moderate risk Terminated

Progesterone 100 mg/ml Injection

Reason Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

The Compounding Pharmacy of America D-1626-2015
Class II · Moderate risk Terminated

Hydroxyprogesterone Caproate

Reason Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

The Compounding Pharmacy of America D-1560-2015